SHERMAN JEFFREY W

SEC Form 4 insider trading activity

SHERMAN JEFFREY W has filed 3 SEC Form 4 filings (28 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Nov 16, 2026.

On the most recent filing, SHERMAN JEFFREY W is listed as Director at Larimar Therapeutics, Inc. Inside the rolling window, SHERMAN JEFFREY W reported 2 open-market purchases totaling $35K in LRMR and no open-market sales. The largest disclosed transaction in the window is a purchase of 5,000 LRMR shares on Feb 27, 2026, worth $25K.

Companies traded

Other insiders at LRMR

Insider Buying

$35K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LRMRPurchase$10KNov 16SEC ↗
LRMRPurchase$25KMar 2SEC ↗
Showing 1–2 of 2
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Aug 28, 2025XERSSale$335K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has SHERMAN JEFFREY W made?

SHERMAN JEFFREY W has filed 3 SEC Form 4 filings (28 transaction rows) across 1 company since 2025.

Which companies does SHERMAN JEFFREY W trade?

SHERMAN JEFFREY W has filed SEC Form 4 disclosures for 1 company, including LRMR.

When was SHERMAN JEFFREY W's most recent SEC Form 4 filing?

SHERMAN JEFFREY W's most recent SEC Form 4 filing on Tracefour is dated Nov 16, 2026.

What is SHERMAN JEFFREY W's total buy and sell value in the current window?

Inside the rolling retention window, SHERMAN JEFFREY W bought $35K and sold $0 based on SEC Form 4 filings.

What was SHERMAN JEFFREY W's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 5,000 LRMR shares on 2026-02-27, worth $25K, per SEC Form 4 filings.